Dolutegravir/Rilpivirine
Brand name: Juluca
Rank #117 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$148.9M
Total Cost
41,081
Total Claims
$148.9M
Total Cost
1,234
Prescribers
$3,624
Cost per Claim
1,334
Beneficiaries
42,777
30-Day Fills
$121K
Avg Cost/Provider
33
Avg Claims/Provider
Share of Medicare Part D Spending
0.05%
of total Medicare Part D spending
$148.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $148.9M total
🔎 Data Overview
At $3,624 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $120,650 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $111,606 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Dolutegravir/Rilpivirine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Danielle Leedy | Nurse Practitioner | Detroit, MI | 287 | $1.0M |
| 2 | Ana Caceres | Nurse Practitioner | Hartford, CT | 272 | $969K |
| 3 | Rodney Kusumi | Infectious Disease | Columbus, OH | 234 | $819K |
| 4 | David Aboulafia | Hematology-Oncology | Seattle, WA | 222 | $778K |
| 5 | Sharon Reiley | Nurse Practitioner | Jacksonville, FL | 230 | $773K |
| 6 | Caitlin Williams | Nurse Practitioner | Thaxton, MS | 216 | $772K |
| 7 | Natalie Vanek | Infectious Disease | Houston, TX | 202 | $722K |
| 8 | Jill Frickenhaus | Nurse Practitioner | New York, NY | 193 | $719K |
| 9 | Mary Eschete | Internal Medicine | Houma, LA | 197 | $705K |
| 10 | David Weinrib | Infectious Disease | Charlotte, NC | 196 | $691K |
| 11 | Josh Lopez | Nurse Practitioner | Elgin, IL | 176 | $648K |
| 12 | Warren Magnus | Family Practice | Las Vegas, NV | 184 | $639K |
| 13 | Ruben Martinez | Family Practice | Harlingen, TX | 178 | $630K |
| 14 | Luis Cisneros | Infectious Disease | San Antonio, TX | 168 | $612K |
| 15 | Jennifer Knight | Nurse Practitioner | New York, NY | 174 | $598K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 114 | Teriparatide (Forteo) | $153.9M | 38,259 |
| 115 | Ixekizumab (Taltz Autoinjector) | $149.8M | 19,972 |
| 116 | Sofosbuvir/Velpatasvir (Epclusa) | $149.4M | 6,544 |
| 117 | Dolutegravir/Rilpivirine (Juluca) | $148.9M | 41,081 |
| 118 | Lisinopril (Lisinopril) | $145.8M | 15,744,768 |
| 119 | Ofatumumab (Kesimpta Pen) | $144.6M | 14,774 |
| 120 | Emtricitab/Rilpiviri/Tenof Ala (Odefsey) | $144.1M | 37,441 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology